Numerion Labs
San Francisco
About Numerion Labs
Numerion Labs is a preclinical pharma company revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Numerion Labs has raised over $174 million from leading venture capital firms to advance our mission to make better medicines faster.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $241.4M
- Funding stage: Late Stage Venture
- Last round: Series D (Mar 2026)
- Website: numerionlabs.ai
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Machine Learning, Medical
Social Profiles
Canonical: https://fsome.com/organization/numerion-labs-26704 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.